This review investigates the role of osteoprotegerin (OPG) in breast cancer, exploring how genetic variations in the OPG gene (TNFRSF11B), its interactions with the RANK/RANKL pathway, and its modulation of cancer-related processes contribute to tumorigenesis. This evidence concerns the gene TNFRSF11B and cancer.